Burger line Burger line Burger line
Logo Logo Logo
Burger line Burger line Burger line
Menu
Sign in
Sign in

EU Approves Takeda’s Dengue Vaccine

EU Approves Takeda’s Dengue Vaccine

The European Commission (EC) has approved Takeda’s dengue Qdenga vaccine for individuals four years and older in preventing dengue, a mosquito-borne disease that can cause severe bleeding and shock.

The approval was supported by results from multiple clinical trials in which the vaccine prevented 80 percent of symptomatic dengue cases at 12 months after vaccination.

The Qdenga vaccine is based on a weakened form of the dengue serotype 2 virus and is designed to protect against four dengue virus serotypes.

December 9, 2022

https://www.fdanews.com/


0 items in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company

We use "cookies*  to ensure the functionality of our website, recognise your browser or device, learn more about your interests, and provide you with essential features and services and for additional purposes, including:

Recognising you when you sign-in to use our services. This allows us to provide you with product recommendations, display personalised content, and provide other customised features and services.
Keeping track of your specified preferences. You may set your preferences through Your Account..
Keeping track of items stored in your shopping basket and personal cabinet.
Conducting research and diagnostics to improve ChemDiv’s content, products, and services.
Delivering content, including ads, relevant to your interests on ChemDiv’s site
Reporting. This allows us to measure and analyse the performance of our services.

By  cookies you give consent to the processing of your personal data, including transfer to third parties. Further information can be found in our privacy policy.

Accept all cookies